Global 3D Medical Imaging Devices Market By Device Type (X-ray Devices, CT, Ultrasound Systems, and MRI), By Application (Oncology, Cardiology, and Orthopedic), By Solution (3D Scanning, 3D Rendering, and 3D Modeling), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Market Overview

The Global 3D Medical Imaging Devices Market size is expected to be worth around USD 28.2 Billion by 2033 from USD 11.9 Billion in 2023, growing at a CAGR of 9.1% during the forecast period from 2024 to 2033.

3D medical imaging is an innovative optical imaging technology used to generate magnified images of the interior of the human body for medical examination purposes. Employing computer-aided design (CAD) or magnetic resonance imaging (MRI), 3D medical imaging creates three-dimensional representations of internal body structures, providing medical practitioners with detailed examination information.

Key types of 3D medical imaging technologies include ultrasound, X-ray, and CT scan imaging techniques. X-rays capture two-dimensional images that are then transformed to mimic three-dimensional imagery for analysis. These imaging methods find applications across many medical specialties such as gynecology, obstetrics, obstetrics, obstetrics cardiology neurology orthopedics oncology as well as end-users such as diagnostic centers, hospitals, research facilities etc.

In 2024, the global market for 3D medical imaging devices reached significant proportions and is forecasted for significant expansion by 2033 with rapid revenue growth projected throughout its forecast period. Industry analysis points to an exponentially growing demand for such devices from Biotechnology and healthcare sectors along with their increased adoption within other areas. This upward trend aligns with evolving market dynamics and consumption patterns that serve as key drivers for both industry and market expansion in the near future.

According to a 2017 United Nations (UN), report, the world’s population over 65 accounted for approximately 13.0%. This number is rising at 3.0% per annum. Geriatrics are more likely to develop musculoskeletal problems and joint problems. Osteoarthritis is the leading cause of death in people over 65 years. It also causes a decrease in quality of life and increases mortality. The market is driven by the rising incidence of life-threatening and chronic diseases around the world.

The U.S. Centers for Disease and Control reports that organized sports have seen a rise in participation. Each year, the U.S. has 30 million people participating in sports. This includes approximately 2 million injuries and 0.5 million doctor visits. There are also 30,000 hospitalizations. Due to the growing demand for point-of-care imaging, and the high population addressable, this has opened up new markets for 3D medical imaging.

Key Takeaways

• Market Size: 3D Medical Imaging Devices Market size is expected to be worth around USD 28.2 Billion by 2033 from USD 11.9 Billion in 2023.
• Market Growth: The market growing at a CAGR of 9.1% during the forecast period from 2024 to 2033.
• Device Type Analysis: Hardware segment commanding 68.6% market share in 2023.
• Application Analysis: Oncology dominates the 3D Medical Imaging Devices Market with 34% market share.
• End-Use Analysis: Hospitals emerge as the primary end-user segment, accounting for 49% of the market share within the 3D Medical Imaging Devices Market.
• Regional Analysis: The North American region has a higher market share, at 36.9%, due to its healthcare systems, such as hospitals and long-term care centers.
• Technological Advancements: Innovations such as 3D mammography, 3D ultrasound, and 3D MRI are enhancing the accuracy and efficiency of diagnostic imaging, leading to better patient outcomes.
• Future Outlook: The market is expected to continue its upward trajectory, driven by increasing healthcare needs, technological innovations, and the expanding application scope of 3D imaging in medical diagnostics.

Device Type Analysis

The 3D Medical Imaging Devices Market is witnessing a significant dominance of hardware, encompassing X-ray Devices, CT Devices, Ultrasound Systems, and MRI Equipment, which collectively hold a commanding 68.6% market share. Among these, X-ray Devices and CT Devices stand out for their widespread adoption in various medical settings due to their ability to produce detailed cross-sectional images of the body.

Meanwhile, Ultrasound Systems offer real-time imaging capabilities, making them indispensable in obstetrics, cardiology, and other diagnostic applications. MRI Equipment, renowned for its non-invasive nature and superior soft tissue contrast, continues to be a preferred choice for detailed anatomical imaging. The prominence of hardware in the 3D medical imaging market underscores the critical role these devices play in facilitating accurate diagnosis, treatment planning, and medical research, driving continued market growth and innovation in the healthcare sector.

The segment ultrasound systems are forecast to grow at a rate of 7.0% during the forecast period. The industry’s dominance and the rise in ultrasound scans all over the globe are the main reasons for the high growth. Siemens Healthineers, for example, introduced the Acuson Sequoia in June 2018. This system uses contrast-enhanced ultrasonic imaging. It also features BioAcoustic technology, which increases the bubble longevity and sensitivity while reducing the diagnosis time.

Application Analysis

Oncology dominates the 3D Medical Imaging Devices Market with 34% market share. Utilization of advanced imaging technologies, including X-ray Devices, CT Devices, Ultrasound Systems and MRI Equipment plays an instrumental role in oncology for early detection, accurate staging and treatment monitoring of various cancers. Healthcare professionals utilize these imaging modalities to visualize tumors with extreme clarity and precision to better tailor patient-specific therapies and improve outcomes.

Cardiology, Orthopedic, and Gynecology applications all make significant contributions to the market landscape, with each meeting specific medical needs. Cardiology uses 3D imaging technology for evaluating cardiac anatomy, function, vascular structures, diagnosis, management of cardiovascular diseases as well as injuries. 3D imaging also facilitates precise evaluations of musculoskeletal conditions such as fractures, joint disorders, sports injuries etc.

Additionally in Gynecology these technologies support comprehensive assessments and management of reproductive health issues improving diagnostic accuracy as well as patient care.

End-Use Analysis

Hospitals emerge as the primary end-user segment, accounting for 49% of the market share within the 3D Medical Imaging Devices Market. Hospitals serve as vital hubs of healthcare delivery, and their presence relies heavily on advanced imaging technologies such as X-ray Devices, CT Devices, Ultrasound Systems and MRI Equipment to support various specialties and diagnostic procedures across a range of medical specialties and diseases. Such tools play an invaluable role in accurate diagnosis, treatment planning and patient monitoring across many conditions and diseases.

Diagnostic Imaging Centers represent another significant end-user segment within the market. These specialized facilities specialize exclusively in providing diagnostic imaging services and offer various imaging modalities for patients referred by healthcare providers. Leveraging their expertise and cutting-edge equipment, Diagnostic Imaging Centers play an essential part in providing timely and accurate diagnoses of medical conditions – thus complementing hospital services while improving overall patient care within healthcare ecosystems.

Key Market Segments

Device Type

Hardware

• X-ray Devices
• CT Devices
• Ultrasound Systems
• MRI Equipment

Software

Application

• Oncology
• Cardiology
• Orthopedic
• Gynecology
• Other Applications

End-use

• Hospitals
• Diagnostic Imaging Centers
• Other End-Users

Drivers

Technological Advancements

One of the main drivers of 3D Medical Imaging Devices market growth is advancements in technology. Advancements like improved resolution, faster scanning times and enhanced software algorithms have significantly expanded capabilities of medical imaging devices allowing healthcare providers to obtain more precise images leading to more precise diagnoses and treatment planning by healthcare providers. Artificial intelligence (AI)/machine learning algorithms further boost efficiency in image analysis which further drives adoption rates of these 3D Medical Imaging devices.

Rising Prevalence of Chronic Diseases

With cancer, cardiovascular diseases, and musculoskeletal disorders becoming more prevalent globally, 3D medical imaging devices have become a necessity to diagnose chronic conditions early and plan tailored treatment programs effectively. 3D medical imaging technologies play a pivotal role in early diagnosis as the global burden increases requiring advanced technologies providing detailed anatomical data thereby driving growth within this market sector.

Trend

Shift Towards Portable and Point-of-Care Devices

At 3D Medical Imaging Devices market, one key trend has been the increase of portable and point-of-care devices. Recent advancements have allowed for lightweight imaging devices which are easily transportable, providing healthcare providers with real time diagnostic capabilities in emergency situations or patient consultations, or for real time imaging in remote or underserved locations.

Furthermore, point-of-care devices enable faster diagnosis and treatment initiation thereby improving patient outcomes while decreasing healthcare costs.

Integration of Artificial Intelligence (AI) and Machine Learning

Another trend shaping the 3D Medical Imaging Devices market is AI/ML integration. AI technology is increasingly being utilized for image analysis, abnormality detection and aiding healthcare professionals when it comes to interpreting imaging data. AI imaging solutions help reduce interpretation errors while simultaneously increasing diagnostic accuracy while streamlining workflow efficiency – further fuelling market growth. As such, there has been an increasing demand for medical imaging devices equipped with these features, driving market expansion.

Restraints

High Cost of Equipment

One key restraint affecting the 3D Medical Imaging Devices market is high costs associated with equipment. CT scanners, MRI machines and ultrasound systems requiring significant investment for procurement, installation and maintenance may become financial strain on healthcare facilities with limited healthcare budgets; while additional expenses such as training infrastructure costs increase the overall expense. As such it limits adoption in some healthcare environments.

Concerns Regarding Radiation Exposure

Another restraint impacting the 3D Medical Imaging Devices market is radiation exposure associated with certain imaging modalities, like CT scans and X-rays. While such techniques provide valuable diagnostic data, they expose patients to potentially hazardous radiation which poses health risks when repeated.

Healthcare providers and patients are becoming aware of such risks; as such they may seek alternative imaging modalities or limit exposure whenever possible in order to reduce market growth.

Opportunity

Emerging Applications in Minimally Invasive Surgery (MIS)

3D Medical Imaging Devices market players see opportunities emerging applications within minimally invasive surgery as one area to explore for expansion. 3D imaging technologies like intraoperative CT and MRI are increasingly utilized as real-time tools for guidance and visualization during minimally invasive surgery procedures. These imaging modalities enable surgeons to accurately navigate complex anatomical structures, identify tumor margins and ensure precise instrument placement resulting in improved surgical outcomes and reduced patient morbidity.

As more minimally invasive procedures become mainstream there is also an increasing demand for advanced 3D medical imaging devices tailored specifically for minimally invasive surgeries presenting opportunities for market expansion.

Growing Focus on Personalized Medicine

As genomics, proteomics, and molecular imaging technologies become more sophisticated they enable healthcare providers to tailor patient treatments directly to individual patient characteristics or disease profiles; 3D medical imaging devices play a pivotal role in this paradigm shift by providing detailed anatomical and functional data that guides treatment decisions or monitor response to treatments; this in turn drives demand for 3D Medical Imaging Devices as personalized medicine becomes mainstream.

Regional Analysis

Geographically, there are five segments of the market: North America, Europe, Asia Pacific, South America, and the Middle East & Africa (MEA). Together, The North American region has a higher market share, at 36.9%, due to its healthcare systems, such as hospitals and long-term care centers. It is expected that the region will experience strong growth because of its well-established healthcare infrastructure, which is superior to those in developing regions. This can be complemented by favorable reimbursement scenarios.

The Asia Pacific is expected to experience significant growth by 2033 due to improvements in healthcare infrastructure and increased medical tourism. But, two major factors hinder the market’s growth: the high cost of 3D imaging devices and the low adoption rate.

Key Regions and Countries

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Player Analysis

The 3D Medical Imaging Devices Market Report offers a thorough examination of both established and emerging players within the market. The report provides detailed lists of key companies, categorized based on the types of products they offer and other relevant factors in the market.

In addition to company profiling and market analysis, the report includes the year of market entry for each mentioned player, providing valuable insights for research analysis conducted by the analysts involved in the report.

Market Key Players

• Siemens Healthineers
• Esaote SpA
• Koninklijke Philips N.V.
• GE Healthcare Ltd.
• Canon Medical Systems
• Shimadzu Corporation
• Hitachi Medical Systems
• DigiRad Corporation
• Del Medical Systems Inc.
• Front Range Mobile Imaging Inc.

Recent Developments

• Siemens Healthineers (November 2023): Siemens Healthineers partnered with Stratasys to advance medical imaging phantoms for computed tomography (CT) imaging. This collaboration leverages Stratasys’ 3D printing technologies and Siemens’ advanced algorithms to create ultra-realistic human anatomy models, improving CT scanner calibration and performance​.
• Esaote SpA (March 2024): Esaote SpA launched its latest 3D ultrasound system, MyLab X8, which integrates advanced imaging technologies to provide enhanced diagnostic accuracy for various clinical applications, including cardiology and obstetrics. This launch aims to address the growing demand for high-resolution imaging in clinical diagnostics.
• Koninklijke Philips N.V. (February 2024): Philips introduced the IntelliSpace Portal 12.0, a new version of their advanced visualization and analysis platform for 3D medical imaging. This platform includes AI-driven tools for more precise image analysis and improved workflow efficiency, particularly in oncology and neurology applications.
• GE Healthcare Ltd. (April 2024): GE Healthcare expanded its 3D imaging product portfolio with the introduction of the Revolution Apex CT scanner. This new scanner offers enhanced image quality and faster scanning times, supporting more accurate diagnoses and streamlined clinical workflows in hospitals and imaging centers.
• Canon Medical Systems (May 2024): Canon Medical Systems acquired a leading AI imaging software company to integrate advanced AI capabilities into their 3D medical imaging devices. This acquisition aims to enhance diagnostic precision and improve patient outcomes by leveraging AI-driven imaging analysis.
• Shimadzu Corporation (January 2024): Shimadzu Corporation launched the Trinias F12, a state-of-the-art 3D angiography system. This new system provides high-resolution vascular imaging, aiding in the accurate diagnosis and treatment of cardiovascular diseases, and is expected to be widely adopted in interventional radiology​.

Report Scope